CORC  > 复旦大学上海医学院
Preliminary Results from a Phase 1 Study of HMPL-523, a Highly Selective Syk Inhibitor, in Chinese Patients with Mature B-Cell Lymphomas
Zhu, Jun; Cao, Junning; Qiu, Lugui; Qi, Junyuan; Song, Yuqin; Tu, Meifeng; Ji, Dongmei; Shen, Weina; Sun, Mingyuan; Hua, Ye
2018
卷号132
会议录BLOOD
语种英语
URL标识查看原文
ISSN号0006-4971
内容类型会议论文
URI标识http://www.corc.org.cn/handle/1471x/3601781
专题复旦大学上海医学院
推荐引用方式
GB/T 7714
Zhu, Jun,Cao, Junning,Qiu, Lugui,et al. Preliminary Results from a Phase 1 Study of HMPL-523, a Highly Selective Syk Inhibitor, in Chinese Patients with Mature B-Cell Lymphomas[C]. 见:.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace